Skip to main content
ATRC logo

ATRC · AtriCure, Inc.

Track ATRC — free
$51.52 -0.94 (-1.79%) At close · Sep 4
Market Cap
$2.62B
Shares
50.87M

ATRC metrics

73 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$51.52
Market cap
$2.62B

Price action

19 metrics
Price change (1W)
+6.1%
Price change (30D)
+24.5%
Price change (3M)
+90.1%
Price change (6M)
+71.6%
Price change (YTD)
+30.2%
Price change (1Y)
+44.5%
Trailing year
Price change (5Y)
-32.5%
52-week high
$52.59
52-week low
$25.86
Change from 52-week high
-2.0%
Change from 52-week low
+99.2%
Annualized volatility
46.7%
Beta
0.6
RSI (14D)
74.2
Price vs SMA 50
+28.6%
Price vs SMA 200
+49.2%
Avg volume (3M)
895,967
Relative volume
0.8
Average dollar volume
$32.79M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
50.87M

Valuation

12 metrics
P / E (TTM)
245.3
Trailing earnings · reciprocal yield 0.4%
PEG ratio
EV / revenue
EV / EBITDA
EV / EBIT
P / sales
4.6×
reciprocal yield 21.7%
P / book
5.1
reciprocal yield 19.7%
FCF yield
2.0%
TTM · current market cap
Buyback yield
P / FCF
49.3
reciprocal yield 2.0%
P / operating cash flow
40.4
reciprocal yield 2.5%
Earnings yield
0.4%

Historical valuation

8 metrics
P / E historical average (3Y)
P / E historical average (5Y)
EV / revenue historical average (3Y)
3.2×
reciprocal yield 31.1%
EV / revenue historical average (5Y)
5.5×
reciprocal yield 18.3%
EV / EBIT historical average (3Y)
EV / EBIT historical average (5Y)
74.2×
reciprocal yield 1.3%
EV / EBITDA historical average (3Y)
EV / EBITDA historical average (5Y)

Dividends & buybacks

7 metrics
Dividend yield
Trailing 12 months
Payout ratio
Shareholder yield
Dividend / share (TTM)
Dividend growth YoY
Dividend growth streak
Last ex-dividend

Earnings calendar

2 metrics
Next earnings
Last earnings
2026-07-23

Profitability

9 metrics
Gross margin
76.3%
Operating margin
2.3%
Trailing 12 months
Net margin
1.9%
Gross profit (TTM)
$434.61M
Operating profit (TTM)
$12.89M
Net income (TTM)
$10.55M
Trailing 12 months
Diluted EPS (TTM)
$0.21
FCF margin
9.3%
Effective tax rate
12.8%

Per share

11 metrics
Revenue per diluted share (TTM)
Gross profit per diluted share (TTM)
Operating profit per diluted share (TTM)
EBITDA per diluted share (TTM)
Net income per diluted share (TTM)
Operating cash flow per diluted share (TTM)
Free cash flow per diluted share (TTM)
Capital expenditures per diluted share (TTM)
R&D per diluted share (TTM)
Stock compensation per diluted share (TTM)
Book value per share
$1.07

Growth

11 metrics
Revenue growth YoY
+12.8%
Year over year
Net income growth YoY
Revenue (TTM)
$569.62M
Trailing 12 months
EPS growth YoY
Shares change YoY
+2.4%
Year over year · more shares
Revenue CAGR (3Y)
+17.4%
Revenue CAGR (5Y)
+20.9%
EPS CAGR (3Y)
EPS CAGR (5Y)
FCF CAGR (3Y)
FCF CAGR (5Y)

Quality

14 metrics
Return on equity
2.0%
Return on assets
1.6%
Debt / equity
Current ratio
4.2
EBITDA (TTM)
Free cash flow (TTM)
$53.11M
Quick ratio
3.2
Interest coverage
2.3
Net debt / EBITDA
Return on invested capital
Trailing 12 months
Net cash
Latest balance sheet
Cash & equivalents
$167.79M
Total assets
$676.64M
Total debt

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$64.94M
Capital expenditures (TTM)
$11.82M
R&D (TTM)
$98.03M
SG&A (TTM)
$323.69M
Stock compensation (TTM)
$47.27M
R&D / revenue
17.2%
Stock compensation / revenue
8.3%

Ownership (13F)

3 metrics
13F filers
254
13F filer change QoQ
+30
Institutional ownership
103.4%

Short interest

3 metrics
Short interest
7.7%
Latest settlement · 6.1 days to cover
Days to cover
6.1d
Short-squeeze score
68 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$2.56M
Insider-sentiment score
15 / 100

Risk flags

1 metrics
Going concern
Key facts CIK 1323885 CUSIP 04963C209 13F (30d) 194 filings 192 filers Visit website Investor relations